APA (7th ed.) Citation

Denkert, C., Minckwitz, G. v., Brase, J. C., Sinn, B. V., Gade, S., Kronenwett, R., . . . Loibl, S. (2015). Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers. Journal of clinical oncology, 33(9), . https://doi.org/10.1200/JCO.2014.58.1967

Chicago Style (17th ed.) Citation

Denkert, Carsten, et al. "Tumor-infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy with or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-positive and Triple-negative Primary Breast Cancers." Journal of Clinical Oncology 33, no. 9 (2015). https://doi.org/10.1200/JCO.2014.58.1967.

MLA (9th ed.) Citation

Denkert, Carsten, et al. "Tumor-infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy with or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-positive and Triple-negative Primary Breast Cancers." Journal of Clinical Oncology, vol. 33, no. 9, 2015, https://doi.org/10.1200/JCO.2014.58.1967.